Brief: Kancera AB Has Been Awarded EU Funding
21/11/2018 14:50
Kancera AB KANC.ST :
* HAS BEEN AWARDED EU FUNDING
* WITHIN FRAMEWORK OF EU HORIZON 2020 RESEARCH PROGRAM GETS
RESEARCH GRANT TOTALING ABOUT EUR 250,000
Source text for Eikon: ID:nWkr1JHvzn
Further company coverage: KANC.ST
Recent news on Novakand Pharma AB
See all newsBrief: Nasdaq Decides To Delist Novakand From First North Growth Market
Brief: Novakand Pharma Extends Peter Selin's CEO Employment
Brief: Novakand Board Proposes New Business Direction, Relisting
Brief: Novakand Pharma Evaluates Options After Decision Not To Execute Reverse Take Over
Brief: Nasdaq Rejects Novakand's Application For Continued Listing